Adlai Nortye is a global clinical-stage biopharmaceutical company that is developing differentiated, innovative immuno-oncology medicines. Adlai Nortye focuses on discovering and developing important new treatments for cancer with a mission to improve patient lives by identifying and developing differentiated innovative medicines that help people live better, live longer. Through close collaborations with global partners, Adlai Nortye have successfully positioned itself in the field of immuno-oncology and h

We have a promising and diverse pipeline consisting of preclinical, early, mid and late stage products, that focus on cancer treatment for unmet medical need and significant commercial opportunities. Through our active partnership programs and original discovery efforts, we are advancing a broad range of development targets with multiple opportunities for success in different types of cancer.